ASTERDM — Aster DM Healthcare Balance Sheet
0.000.00%
- IN₹391.10bn
- IN₹401.02bn
- IN₹46.43bn
Annual balance sheet for Aster DM Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,695 | 3,965 | 1,060 | 13,611 | 14,854 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24,023 | 25,047 | 2,831 | 3,841 | 3,072 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 40,965 | 49,216 | 141,653 | 19,015 | 19,478 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 66,404 | 78,036 | 30,500 | 39,186 | 43,709 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 125,462 | 148,812 | 179,913 | 66,064 | 81,120 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 35,586 | 46,553 | 112,883 | 8,792 | 9,792 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 85,928 | 104,331 | 134,315 | 31,783 | 35,361 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 39,534 | 44,481 | 45,598 | 34,281 | 45,759 |
| Total Liabilities & Shareholders' Equity | 125,462 | 148,812 | 179,913 | 66,064 | 81,120 |
| Total Common Shares Outstanding |